Skip to main content
Top
Published in: Familial Cancer 1/2007

Open Access 01-03-2007 | Original Paper

Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data

Authors: D. A. van Dijk, M. J. Oostindiër, W. M. Kloosterman-Boele, P. Krijnen, H. F. A. Vasen, Hereditary Tumor Study Group of the Comprehensive Cancer Centre West (CCCW)

Published in: Familial Cancer | Issue 1/2007

Login to get access

Abstract

In the diagnostic work-up of hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome), high-risk patients can be identified using information from the family history on cancer (‘Amsterdam criteria’ and ‘Bethesda guidelines’). To investigate to what extent the medical specialists apply these criteria to patients with colorectal carcinoma and a suspicion of HNPCC, we collected information on diagnostic work-up of 224 patients of seven hospitals in the region of the Comprehensive Cancer Centre West in Leiden, The Netherlands. These patients were diagnosed with colorectal cancer between 1999 and 2001 and satisfied at least one of the Bethesda guidelines. A complete family history was recorded for 38 of the 244 patients (16%). Patients with a complete family history were more likely to be referred to the Clinical Genetic Centre than those with an incomplete or absent family history (53% vs. 13% and 4%, respectively; P < 0.0001), and more likely to be analyzed for microsatellite instability (MSI), which is a characteristic of HNPCC (34% vs. 6% and 1%, respectively; P < 0.0001). We conclude that the family history is neglected in the majority of patients with colorectal cancer and MSI-analysis is only performed in a small proportion of the patients that meet the guidelines for this analysis.
Literature
1.
2.
go back to reference Peltomaki P, Vasen H (2004) Mutations associated with HNPCC predisposition—Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20:269–276PubMed Peltomaki P, Vasen H (2004) Mutations associated with HNPCC predisposition—Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20:269–276PubMed
3.
go back to reference Vasen HF (2000) Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 18(suppl):81S-92SPubMed Vasen HF (2000) Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol 18(suppl):81S-92SPubMed
4.
go back to reference de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P et al (2003) Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 52:1752–1755PubMedCrossRef de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P et al (2003) Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 52:1752–1755PubMedCrossRef
5.
go back to reference de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G et al (2002) Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 45:1588–1594PubMedCrossRef de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G et al (2002) Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 45:1588–1594PubMedCrossRef
6.
go back to reference Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15 year trial on screening for colorectal cancer in families with Hereditary Non-Polyposis Colorectal Carcinoma. Gastroenterology 118:969–971CrossRef Jarvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15 year trial on screening for colorectal cancer in families with Hereditary Non-Polyposis Colorectal Carcinoma. Gastroenterology 118:969–971CrossRef
7.
go back to reference De Jong AE, van Puijenbroek M, Hendriks Y et al (2004) Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Canc Res 10:972–980CrossRef De Jong AE, van Puijenbroek M, Hendriks Y et al (2004) Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Canc Res 10:972–980CrossRef
8.
go back to reference Kievit W, de Bruin JH, Adang EM et al (2005) Cost effectiveness of a new strategy to identify HNPCC patients. Gut 54:97–102PubMedCrossRef Kievit W, de Bruin JH, Adang EM et al (2005) Cost effectiveness of a new strategy to identify HNPCC patients. Gut 54:97–102PubMedCrossRef
9.
go back to reference Menko FH, Griffioen G, Wijnen JT et al (1999) Genetics of colorectal cancer. I. Non-polyposis and polyposis forms of hereditary colorectal cancer. Ned Tijdschr Geneeskd 143:1201–1206PubMed Menko FH, Griffioen G, Wijnen JT et al (1999) Genetics of colorectal cancer. I. Non-polyposis and polyposis forms of hereditary colorectal cancer. Ned Tijdschr Geneeskd 143:1201–1206PubMed
10.
go back to reference Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1997) A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Canc Inst 89:1758–1762CrossRef Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1997) A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Canc Inst 89:1758–1762CrossRef
11.
go back to reference Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268PubMedCrossRef Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268PubMedCrossRef
12.
go back to reference Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453–1456PubMedCrossRef Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453–1456PubMedCrossRef
Metadata
Title
Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data
Authors
D. A. van Dijk
M. J. Oostindiër
W. M. Kloosterman-Boele
P. Krijnen
H. F. A. Vasen
Hereditary Tumor Study Group of the Comprehensive Cancer Centre West (CCCW)
Publication date
01-03-2007
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 1/2007
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-006-9114-8

Other articles of this Issue 1/2007

Familial Cancer 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine